It currently remains unclear whether the selective inhibition of PDGFR is sufficient to reduce pulmonary fibrosis by targeting a single molecule, and also if PDGFR-α or -β is a better target for reducing fibrogenesis in the lungs. The gene discussed is PDGFRA; the disease is pulmonary fibrosis.